Nuclear magnetic resonance (NMR) spectroscopy uses the magnetic spin properties of atomic nuclei within a molecule to identify atoms that are close together in space (either because they are bonded together or because folds of a protein chain bring them together). This information is used to derive a three-dimensional model of a protein in solution (a 'solution structure').
Only certain isotopes, such as 1 H, 13 C, 15 N or 31 P, have a magnetic spin; isotopes such as 12 C or 16 O are NMR inactive. Protein samples are now routinely enriched with 13 C and 15 N isotopes to simplify the NMR data by making it possible to identify particular isotopes and chemical groups. During NMR spectroscopy, protein molecules in solution are placed in a magnetic field, so that the magnetic moments of individual nuclei can align with the field. When the sample is irradiated with pulses of radio frequency electromagnetic radiation, NMR-active nuclei will resonate at characteristic frequencies. These different frequencies are obtained as NMR peaks -relative to a reference signal -and are called chemical shifts. The chemical shift of an atomic nucleus depends on its molecular environment and is different for each atom in a protein molecule, unless two atoms are magnetically equivalent. For example, protons within individual side chain CH 3 groups of valine are magnetically equivalent but the protons of adjacent side chain CH 3 groups of valine are not, because of their stereochemical positioning.
Multi-dimensional NMR
The standard NMR spectrum of absorption versus frequency (or chemical shift) is a one-dimensional spectrum. In principle, this should give a unique peak for each NMRactive nucleus in a molecule but in practice the peaks often overlap because of the limited resolving power of the technique. To circumnavigate this problem, NMR is expanded into two or more dimensions, which enables plots of correlations between nuclei. Different types of NMR experiment display correlations that indicate whether two nuclei share a 'throughbond' or 'through-space' characteristic, in other words, whether they are bonded together, or simply on adjacent folds of the molecule. Two-dimensional NMR can involve 1 H, 1 H correlations (known as homonuclear) or, for isotopically enriched proteins, 1 H, 13 C or 1 H, 15 N correlations (known as heteronuclear). Two-dimensional NMR spectra are displayed as contour plots with each axis defining a particular type of nucleus (Figure 1 ). Expanding into a third dimension produces several combinations including: 1 H, 1 H, 13 C; 1 H, 1 H, 15 N; or 1 H, 13 C, 15 N. A threedimensional NMR spectrum is displayed as slices of twodimensional NMR data.
Obtaining a protein structure
Three-dimensional structural information is obtained primarily from 'through-space' NMR experiments involving the 'nuclear Overhauser effect' (NOE). The NOE is a nuclear relaxation effect, the intensity of which is a measure of the distance between two nuclei that are close in space in the folded molecule -even though they may be quite distant in the primary sequence of the protein. NOEs are observed in specific nuclear Overhauser effect spectroscopy (NOESY) NMR experiments. The intensity of NOESY peaks can be classified as strong (reflecting nuclei that are less than 3 Å apart in the molecule), medium (less than 4 Å apart) and weak (less than 6 Å). These classifications define the basis of so-called NOE 'distance constraints'.
Although NOESY experiments provide insights into which amino acid residues are close in space in the folded molecule, before the data can be used each NMR peak must be assigned to its corresponding amino acid along the polypeptide chain of the protein. This is done via the process of 'sequential assignment' which uses specific through-bond NMR experiments to correlate nuclei that are connected by one or many bonds. Sequential assignment enables the designation of NMR peaks to individual nuclei within amino acids and enables the structural biologist to string adjacent amino acids residues together in a sequential fashion. Results from this stage can be overlaid onto data from other NMR experiments that determine the nature of the side chain for each residue to complete the assignment strategy.
Once all NOEs are assigned to a particular amino acid and measured for intensity, an NOE list is produced showing all contacts in the molecule. Structure-calculating programs such as XPLOR or DYANA take these NOE data, together with the sequence for the protein, and attempt to create a 'fold' for the molecule that satisfies as many of the NOE distance constraints as possible. Many programs use a combination of bond, angle and atomic energy criteria to define reasonable folds for the protein. The final structural energy calculated (energy data), together with a list of the NOEs that violate the distance criteria (violations data), give an indication of how well the structure fits the NMR data.
NOE data can be distorted by spin-diffusion, especially when the structure of larger molecules is being determined. In spin-diffusion, the nuclear relaxation effect is propagated between two nuclei that are not necessarily close in space. This results in NOE contacts being observed that imply two nuclei are close in space when, in fact, they are not. Altering the NMR conditions of NOESY experiments can give an indication of the effects of spindiffusion on the data.
In addition to NOESY data, specific NMR experiments can be used to derive data for dihedral angles, hydrogen bond donors and stereospecific nuclei. These data are used to produce additional 'constraints' lists which can be entered into the structure-calculating program and so increase the precision of the final structure. Dihedral angles are obtained from so-called J coupling constants, which describe the hyperfine splitting of an NMR peak because of the effect on its local environment of non-equivalent nuclei that are two, three or four bonds away.
Hydrogen bond donors are ascertained from deuterium exchange experiments, which follow the exchange of labile protons with time. The final structure is reached by analysing violations data and energy data for each individual structure calculated from all the constraints used and modifying the constraints list so that all violations are satisfied in subsequent calculations. It may also be necessary to modify the initial backbone and side-chain assignments on the strength of the violations data. This iterative process takes several rounds of calculation.
Assessing the quality of structures
Final NMR structures should satisfy the energy criteria outlined above and have no violations outside experimental error for all constraints used in their calculation. In addition, all NMR structures are calculated as an ensemble of structures that are said to converge on an average point. Most NMR structure papers display an ensemble of more than 20 calculated structures, superimposed so that readers can see well-defined and poorly defined regions. An ensemble of 26 structures is shown in Figure 2a . Poorly defined regions of the structure aren't necessarily due to poor experimental method or data analysis but can result from loop or linker regions in a protein that have very few NOEs defining them.
To quantify these data, the root mean square deviation (r.m.s.d.) from the average structure of the ensemble for backbone and side chain atoms is calculated. Most structures currently published have r.m.s.d. values over the structured regions of less than 0.5 Å, but side chain r.m.s.d. values are invariably greater (1 Å or more). The smaller the reported r.m.s.d., the more precise the structure is. In addition, there are several computer packages that assist in determining the quality of structures by producing Ramachandran and other plots to indicate the defined secondary structure elements and whether they adhere to rules governing the orientation and distances of individual bonds and atoms.
Most publications show a ribbon model of the structure that clearly indicates the secondary structure of the protein (Figure 2b ). The ribbon model can either be the averaged structure from the r.m.s.d. values or the structure from the ensemble which is closest to the r.m.s.d. values. Finally, it is worth remembering that any NMR structure is only the result of the data analysed so, although it may be precise, it is not necessarily an accurate representation of the protein in question, in vivo, for example.
Other uses of NMR
NMR spectroscopy can also be used to obtain other useful information about proteins. It is increasingly common to publish information about the dynamic motion within proteins using NMR relaxation data. When an NMR-active nucleus is detected, this involves an energy transfer process (like any spectroscopic technique) and that nucleus needs to relax back to its initial state. NMR relaxation occurs via two major mechanisms, called spin-lattice and spin-spin relaxation, which are governed by rate constants T 1 and T 2 , respectively. Measurement of these relaxation rate constants provides information on the internal motions within the molecule and can indicate flexible regions that are of significance to the function of the protein.
The interactions of proteins with other molecules (proteins, nucleic acids, peptides or other ligands) have also been studied by comparing chemical shift and relaxation data for a protein with and without its interaction component. Those amino acid residues in contact with the interacting component will have large chemical shift or relaxation rate changes. This enables the definition of an interacting surface that can be used to design mutagenesis studies probing the protein's function. Interaction studies by NMR have been used to advance drug discoveries by adding libraries of molecules to a protein and studying the changes in chemical shift. NMR has also been used to study protein folding, either by heating the sample to the point at which it beings to unfold or by adding destabilizing agents and attempting to characterize the structure of the partially folding states.
Current limitations, and the future
Protein NMR spectroscopy does have its limitations. It has so far been used mainly for small proteins with molecular weight of less than 30 kDa, although a handful of publications have now reported the NMR study of proteins up to 40-50 kDa. Larger proteins typically have faster relaxation rates, which results in fatter NMR peaks that tend to merge with one another. Many structures have now been achieved with the aid of deuterium ( 2 D) labelling, which slows down spin-spin and spin-lattice relaxation, giving sharper peaks and better signals.
Because NMR spectroscopy determines structure in solution, it can only be used for proteins that are stable in solution and do not aggregate at concentrations of around 1 mM. Problems have also been encountered with the production of isotopically enriched proteins and also with the overexpression and purification of certain proteins.
NMR spectrometers with higher magnetic fields will improve the sensitivity and resolution of the data obtainable. The most powerful NMR spectrometers currently available are 800 MHz (so-called because that is the frequency at which they cause a 1 H nucleus to resonate) but work is under way to create stable 1000 MHz spectrometers. A problem arises with such high frequencies as we approach the microwave region of the electromagnetic spectrum; it would be undesirable to 'cook' your protein as you are trying to characterize it.
As the technological side of NMR advances, more proteins will become accessible to the technique. It is already obvious that the future of protein NMR lies with the medical or pharmaceutical applications of knowing a protein's structure and it is this area that will fuel further advances with the technique.
